| http://www.w3.org/ns/prov#value | - In one aspect, the antibody according to the invention and as described herein, particularly a monoclonal antibody including any functionally equivalent antibody or functional parts thereof is capable of decreasing the total amount of soluble A?? in the brain of an animal, particularly a mammal, but especially a human suffering from a disease or condition associated with increased concentrations o
|
